Financial News
All News about Aldeyra Therapeu
![](https://mms.businesswire.com/media/20211021005142/en/918519/5/ALDX_logo_JPEG.jpg)
![](https://mms.businesswire.com/media/20210909005214/en/904305/5/ALDX_logo_JPEG.jpg)
![](https://mms.businesswire.com/media/20210902005445/en/902582/5/ALDX_logo_JPEG.jpg)
Aldeyra Therapeutics to Participate in Upcoming Virtual Investor Conferences
September 02, 2021
Via Business Wire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cells-1872666_1920_84.jpg)
Via Benzinga
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/christina-victoria-craft-whsnkiwwpec-unsplash.jpg)
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template.jpg)
Aldeyra Therapeutics (ALDX) Q2 2021 Earnings Call Transcript
August 07, 2021
Via The Motley Fool
Topics
Earnings
Exposures
Financial
![](https://mms.businesswire.com/media/20210805005246/en/896567/5/ALDX_logo_JPEG.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_1329.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://mms.businesswire.com/media/20210804005122/en/895933/5/ALDX_logo_JPEG.jpg)
![](https://mms.businesswire.com/media/20210803005225/en/895662/5/ALDX_logo_JPEG.jpg)
![](https://mms.businesswire.com/media/20210729005551/en/894882/5/ALDX_logo_JPEG.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/girl-with-red-hat-lm1kouw8kaa-unsplash.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_1114.png)
Aldeyra Stock Trading Higher On FDA Orphan Drug Tag For Primary Vitreoretinal Lymphoma Candidate
July 20, 2021
Via Benzinga
Exposures
Product Safety
![](https://mms.businesswire.com/media/20210720005404/en/892439/5/ALDX_logo_JPEG.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://mms.businesswire.com/media/20210701005178/en/888981/5/ALDX_logo_JPEG.jpg)
![](https://mms.businesswire.com/media/20210527005193/en/881411/5/ALDX_logo_JPEG.jpg)
![](https://cdn.benzinga.com/files/imagecache/story_image_685x375C/images/story/2012/austin-distel-empz7yrzogw-unsplash_7.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/austin-distel-empz7yrzogw-unsplash_7.jpg)
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template.jpg)
![](https://mms.businesswire.com/media/20210506005303/en/876476/5/ALDX_logo_JPEG.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://mms.businesswire.com/media/20210429005131/en/874664/5/ALDX_logo_JPEG.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/laboratory-2815640_1920_1_8.jpg)
Via Benzinga
Exposures
Product Safety
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_191.png)
![](https://mms.businesswire.com/media/20210428006176/en/874824/5/ALDX_logo_JPEG.jpg)
![](https://g.foolcdn.com/editorial/images/623434/red-line-falling-100-bill.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.